889 related articles for article (PubMed ID: 17331416)
21. New aspects of vulvar cancer: changes in localization and age of onset.
Hampl M; Deckers-Figiel S; Hampl JA; Rein D; Bender HG
Gynecol Oncol; 2008 Jun; 109(3):340-5. PubMed ID: 18407339
[TBL] [Abstract][Full Text] [Related]
22. [Type and frequency of gynecological tumors in the Gondar region of Ethiopia].
Donat H; Dietzmann KR; Icunnoamlack T; Gizaw Z; Rudolf K; Halle H; Seboxa T
Zentralbl Gynakol; 1990; 112(19):1227-37. PubMed ID: 2267876
[TBL] [Abstract][Full Text] [Related]
23. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
24. Linear trend analysis of patients with cervical cancer treated at the Institute of Oncology Vojvodina in 2001-2007.
Nincic D; Mandic A; Dugandzija T; Zivaljevic M; Rajovic J; Vojinovic D
J BUON; 2009; 14(4):669-72. PubMed ID: 20148460
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
[TBL] [Abstract][Full Text] [Related]
26. [Invasive neoplasms of the female genital system. Clinical-epidemiological considerations].
Corrado F; Noccioli G
Minerva Ginecol; 1994 Nov; 46(11):601-5. PubMed ID: 7854563
[TBL] [Abstract][Full Text] [Related]
27. Synchronous primary tumors of the female genital tract: a single center experience.
Gungor T; Kanat-Pektas M; Ustunyurt E; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 May; 279(5):667-72. PubMed ID: 18802716
[TBL] [Abstract][Full Text] [Related]
28. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
29. [Preservation of fertility in gynaecologic cancers].
Querleu D; Gladieff L; Delannes M; Mery E; Ferron G; Rafii A
Bull Cancer; 2008 May; 95(5):487-94. PubMed ID: 18541512
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiology of the gynecological and mammary cancer to the HOMEL and in the CUGO Cotonou, Bénin].
Tonato Bagnan JA; Denakpo JL; Aguida B; Hounkpatin L; Lokossou A; De Souza J; Perrin RX
Bull Cancer; 2013 Feb; 100(2):141-6. PubMed ID: 23449498
[TBL] [Abstract][Full Text] [Related]
31. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
[TBL] [Abstract][Full Text] [Related]
32. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
33. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J
Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390
[TBL] [Abstract][Full Text] [Related]
34. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
Beiki O; Allebeck P; Nordqvist T; Moradi T
Eur J Cancer; 2009 Jan; 45(1):107-18. PubMed ID: 18829301
[TBL] [Abstract][Full Text] [Related]
35. [Clinical aspects of genital cancer in women].
Schindler AE; Hügle I; Donath EM
Geburtshilfe Frauenheilkd; 1984 Oct; 44(10):636-9. PubMed ID: 6335116
[TBL] [Abstract][Full Text] [Related]
36. [Malignant tumors of the genitalia in girls].
Bokhman IaV; Nechaeva ID; Maksimov SIa; Kutusheva GF; Kolygin BA
Vopr Onkol; 1986; 32(1):74-80. PubMed ID: 3511609
[TBL] [Abstract][Full Text] [Related]
37. Clear cell tumors of the female genital tract.
Matias-Guiu X; Lerma E; Prat J
Semin Diagn Pathol; 1997 Nov; 14(4):233-9. PubMed ID: 9383823
[TBL] [Abstract][Full Text] [Related]
38. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
[TBL] [Abstract][Full Text] [Related]
39. Influence of body mass index on prognosis in gynecological malignancies.
Münstedt K; Wagner M; Kullmer U; Hackethal A; Franke FE
Cancer Causes Control; 2008 Nov; 19(9):909-16. PubMed ID: 18392944
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
